Stockreport

Syros Announces 2018 Strategic Priorities and Expected Milestones

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF On Track to Report Clinical Data on SY-1425 Combinations and SY-1365 Initial Expansion of Phase 1 Clinical Trial of SY-1365 to Focus on Ovarian C [Read more]